Grassley Expresses Concern Over New FDA Guidelines on Human Testing of Experimental Drugs
M E M O R A N D U M To: Reporters and EditorsFr: Jill Gerber for Chairman Grassley, 202/224-6522Re: New FDA guidelines on human testing by drugmakersDa: Thursday, Jan. 12, 2006 Today the Food and Drug Administration released relaxed guidelines for human testing bydrugmakers. The guidelines are meant to apply more modern scientific techniques […]
Interviews with Former SFBC International Inc. Executives Over Safety, Ethics Allegations
M E M O R A N D U M To: Reporters and EditorsRe: SFBC International Inc.Da: Wednesday, Jan. 11, 2006 Sen. Chuck Grassley, chairman of the Committee on Finance, made the following commenttoday after his committee investigators interviewed two former executives of SFBC InternationalInc., a pharmaceutical research company that the committee is reviewing for […]
Grassley: Bahrain Trade Pact is Good for U.S. Farmers, Businesses
M E M O R A N D U M To: Reporters and EditorsRe: President’s signing of the United States-Bahrain Free Trade Agreement Implementation ActDa: Wednesday, Jan. 11, 2006 Today President Bush signed into law the United States-Bahrain Free Trade AgreementImplementation Act. Sen. Chuck Grassley, chairman of the Committee on Finance, with jurisdictionover international trade, […]
Grassley, Baucus Seek More Details of Drug Company Grant Money to Promote Particular Medicines
WASHINGTON — Sens. Chuck Grassley and Max Baucus are continuing their review ofdrug company “educational grants” to promote particular medicines by seeking more details of thepractice from many major drug companies. The senators, who began their review last year, areconcerned that sales and marketing personnel – rather than medical professionals – continue to awarddrug company […]
Grassley Expresses Concern on Taxpayer Rights in IRS Frozen Refunds Cases
M E M O R A N D U M To: Reporters and EditorsFr: Jill Gerber for Chairman Grassley, 202/224-6522Re: National Taxpayer Advocate’s 2005 Annual Report to CongressDa: Tuesday, Jan. 10, 2006 Sen. Chuck Grassley, chairman of the Committee on Finance, with Senate jurisdiction over the Internal Revenue Service, today made the following comment on […]
Grassley Seeks Details of CMS Employees’ Travel to Lavish Medicare Contractor Meetings
WASHINGTON – Sen. Chuck Grassley, chairman of the Committee on Finance, is askingthe Centers for Medicare and Medicaid Services for details of key employees’ travel to conferencesat lavish resorts sponsored by Medicare contractors. The employees are responsible for overseeingmore than $300 million in taxpayer dollars annually given to the contractors, called “QualityImprovement Organizations.” “As you […]
Grassley Questions Red Cross Board on Its Practices, Effectiveness
WASHINGTON — Sen. Chuck Grassley, Chairman of the Committee on Finance, is asking questions of the Board that governs the American Red Cross following the recent resignation of the charity’s President and CEO. “It’s time for the Red Cross Board to start answering questions about its role in the turmoil at the top of this […]
Grassley Urges Portman to Notify Congress of U.S.-Peru Free Trade Agreement
WASHINGTON – Sen. Chuck Grassley, chairman of the Committee on Finance, with Senate jurisdiction over international trade, today urged United States Trade Representative Rob Portman tonotify Congress of his intent to have the United States enter into a free trade agreement with Peru. Grassley said the timely notification is important to ensure timely congressional consideration […]
Chairman Grassley seeks to keep access to therapy services for Medicare beneficiaries
WASHINGTON — Sen. Chuck Grassley today urged the administration to delay enforcing therapy caps that will harm stroke victims and other Medicare beneficiaries if the caps take effect as scheduled on January 1, 2006, due to Senate Democrat leaders delaying final congressional action on a comprehensive deficit reduction bill. Grassley has long worked to ensure […]
Chairman Grassley says review will continue into allegations of problems with human subject drug research
WASHINGTON — Sen. Chuck Grassley said today that the Finance Committee will continue its review of allegations about abusive practices in human subject research of pharmaceutical drugs. Consideration by the Senate committee began after news reports by Bloomberg News describing practices that have left people participating in the studies uninformed and at risk, in addition […]